Public Profile

Piramal Pharma Limited

Piramal Pharma Limited, a prominent player in the global pharmaceutical industry, is headquartered in India and operates extensively across key regions, including North America, Europe, and Asia. Founded in 1988, the company has achieved significant milestones, establishing itself as a leader in both contract development and manufacturing, as well as in the formulation of complex generics. Piramal Pharma's core offerings include a diverse range of pharmaceutical products and services, with a strong emphasis on innovative drug delivery systems and advanced therapies. Their commitment to quality and sustainability sets them apart in a competitive market. With a robust portfolio and a focus on research and development, Piramal Pharma Limited continues to enhance its market position, contributing to healthcare solutions worldwide.

DitchCarbon Score

How does Piramal Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

43

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Piramal Pharma Limited's score of 43 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

Let us know if this data was useful to you

Piramal Pharma Limited's reported carbon emissions

In 2024, Piramal Pharma Limited reported total greenhouse gas emissions of approximately 56230000 kg CO2e for Scope 1, about 79415000 kg CO2e for Scope 2, and a significant 499659000 kg CO2e for Scope 3 emissions. This reflects a comprehensive approach to measuring their carbon footprint across all scopes of emissions. Piramal Pharma has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the base year. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions, which includes emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, and the use of sold products, also by FY2030. These targets align with industry standards and demonstrate Piramal Pharma's commitment to addressing climate change and reducing its environmental impact. The company is actively working towards these goals, contributing to a more sustainable future in the pharmaceutical sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
41,396,000
00,000,000
00,000,000
00,000,000
Scope 2
74,243,220
00,000,000
00,000,000
00,000,000
Scope 3
477,407,000
-
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Piramal Pharma Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Piramal Pharma Limited is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Piramal Pharma Limited is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Divis Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Laurus Labs

IN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Syngene

IN
Health and social work services (85)
Updated about 22 hours ago

Hexagon Nutrition Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Dr Reddys Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Glenmark Pharmaceuticals

IN
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers